These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 25324987)

  • 21. Efficacy of topical alpha ointment (containing natural henna) compared to topical hydrocortisone (1%) in the healing of radiation-induced dermatitis in patients with breast cancer: a randomized controlled clinical trial.
    Ansari M; Farzin D; Mosalaei A; Omidvari S; Ahmadloo N; Mohammadianpanah M
    Iran J Med Sci; 2013 Dec; 38(4):293-300. PubMed ID: 24293782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topical silver sulfadiazine for the prevention of acute dermatitis during irradiation for breast cancer.
    Hemati S; Asnaashari O; Sarvizadeh M; Motlagh BN; Akbari M; Tajvidi M; Gookizadeh A
    Support Care Cancer; 2012 Aug; 20(8):1613-8. PubMed ID: 22006502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of acute skin toxicity of breast radiotherapy using thermography: Results of a prospective single-centre trial.
    Maillot O; Leduc N; Atallah V; Escarmant P; Petit A; Belhomme S; Sargos P; Vinh-Hung V
    Cancer Radiother; 2018 May; 22(3):205-210. PubMed ID: 29678596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children.
    Wahn U; Bos JD; Goodfield M; Caputo R; Papp K; Manjra A; Dobozy A; Paul C; Molloy S; Hultsch T; Graeber M; Cherill R; de Prost Y;
    Pediatrics; 2002 Jul; 110(1 Pt 1):e2. PubMed ID: 12093983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A monocentric, open-label randomized standard-of-care controlled study of XONRID®, a medical device for the prevention and treatment of radiation-induced dermatitis in breast and head and neck cancer patients.
    Ingargiola R; De Santis MC; Iacovelli NA; Facchinetti N; Cavallo A; Ivaldi E; Dispinzieri M; Franceschini M; Giandini C; Romanello DA; Di Biaso S; Sabetti M; Locati L; Alfieri S; Bossi P; Guglielmo M; Macchi F; Lozza L; Valdagni R; Fallai C; Pignoli E; Orlandi E
    Radiat Oncol; 2020 Aug; 15(1):193. PubMed ID: 32791985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The treatment of inflammatory facial dermatoses with topical corticosteroids: focus on clocortolone pivalate 0.1% cream.
    Kircik LH; Del Rosso JQ
    J Drugs Dermatol; 2012 Oct; 11(10):1194-8. PubMed ID: 23134984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing the Validity of Clinician Advice That Patients Avoid Use of Topical Agents Before Daily Radiotherapy Treatments.
    Baumann BC; Verginadis II; Zeng C; Bell B; Koduri S; Vachani C; MacArthur KM; Solberg TD; Koumenis C; Metz JM
    JAMA Oncol; 2018 Dec; 4(12):1742-1748. PubMed ID: 30347008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preemptive treatment with Xonrid®, a medical device to reduce radiation induced dermatitis in head and neck cancer patients receiving curative treatment: a pilot study.
    Iacovelli NA; Naimo S; Bonfantini F; Cavallo A; Bossi P; Fallai C; Pignoli E; Alfieri S; Bergamini C; Favales F; Orlandi E
    Support Care Cancer; 2017 Jun; 25(6):1787-1795. PubMed ID: 28108819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural oil-based emulsion containing allantoin versus aqueous cream for managing radiation-induced skin reactions in patients with cancer: a phase 3, double-blind, randomized, controlled trial.
    Chan RJ; Mann J; Tripcony L; Keller J; Cheuk R; Blades R; Keogh S; Poole C; Walsh C
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):756-64. PubMed ID: 25151541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical steroid versus placebo for the prevention of radiation dermatitis in head and neck cancer patients receiving chemoradiotherapy: the study protocol of J-SUPPORT 1602 (TOPICS study), a randomized double-blinded phase 3 trial.
    Zenda S; Yamaguchi T; Yokota T; Miyaji T; Mashiko T; Tanaka M; Yonemura M; Takeno M; Okano T; Kawasaki T; Nakamori Y; Ishii S; Shimada S; Kanamaru M; Uchitomi Y
    BMC Cancer; 2018 Sep; 18(1):873. PubMed ID: 30189840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of PAC-14028 cream - a novel, topical, nonsteroidal, selective TRPV1 antagonist in patients with mild-to-moderate atopic dermatitis: a phase IIb randomized trial.
    Lee YW; Won CH; Jung K; Nam HJ; Choi G; Park YH; Park M; Kim B
    Br J Dermatol; 2019 May; 180(5):1030-1038. PubMed ID: 30623408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The incidence of postoperative radiotherapy-induced acute dermatitis in breast cancer and its influencing factors for Chinese women.
    Ding J; Guo Y; Li Q; Chen J; Hu P; Liu Q; Cao Y; Wu J
    Onco Targets Ther; 2018; 11():1665-1670. PubMed ID: 29615841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prophylaxis and management of acute radiation-induced skin reactions: a systematic review of the literature.
    Salvo N; Barnes E; van Draanen J; Stacey E; Mitera G; Breen D; Giotis A; Czarnota G; Pang J; De Angelis C
    Curr Oncol; 2010 Aug; 17(4):94-112. PubMed ID: 20697521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topical use of phytotherapic cream (Capilen® cream) to prevent radiodermatitis in breast cancer: a prospective historically controlled clinical study.
    Stefanelli A; Forte L; Medoro S; Sgualdo A; Lombardo D; Zini G; Maronta D; Rainieri E; Pascale G; Bagnolatti P; Colella M; Princivalle S; Fiorica F
    G Ital Dermatol Venereol; 2014 Feb; 149(1):107-13. PubMed ID: 24566571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A double-blind, randomised, vehicle-controlled clinical study to evaluate the efficacy of MAS065D in limiting the effects of radiation on the skin: interim analysis.
    Leonardi MC; Gariboldi S; Ivaldi GB; Ferrari A; Serafini F; Didier F; Mariani L; Castiglioni S; Orecchia R
    Eur J Dermatol; 2008; 18(3):317-21. PubMed ID: 18474463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical Betamethasone Valerate As a Prophylactic Agent to Prevent Acute Radiation Dermatitis in Head and Neck Malignancies: A Randomized, Open-Label, Phase 3 Trial.
    Menon A; Prem SS; Kumari R
    Int J Radiat Oncol Biol Phys; 2021 Jan; 109(1):151-160. PubMed ID: 32853709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic effect of recombinant human epidermal growth factor (RhEGF) on mucositis in patients undergoing radiotherapy, with or without chemotherapy, for head and neck cancer: a double-blind placebo-controlled prospective phase 2 multi-institutional clinical trial.
    Wu HG; Song SY; Kim YS; Oh YT; Lee CG; Keum KC; Ahn YC; Lee SW
    Cancer; 2009 Aug; 115(16):3699-708. PubMed ID: 19514089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical epidermal growth factor for the improvement of acne lesions: a randomized, double-blinded, placebo-controlled, split-face trial.
    Kim HK; Yeo IK; Li K; Kim BJ; Kim MN; Hong CK
    Int J Dermatol; 2014 Aug; 53(8):1031-6. PubMed ID: 24962549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Silver clear nylon dressing is effective in preventing radiation-induced dermatitis in patients with lower gastrointestinal cancer: results from a phase III study.
    Niazi TM; Vuong T; Azoulay L; Marijnen C; Bujko K; Nasr E; Lambert C; Duclos M; Faria S; David M; Cummings B
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e305-10. PubMed ID: 22652101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Natural Cream-to-Powder Formulation Developed for the Prevention of Diaper Dermatitis in Diaper-Wearing Infants and Children: Barrier Property and In-Use Tolerance Studies.
    Gunt HB; Levy SB; Lutrario CA
    J Drugs Dermatol; 2018 May; 17(5):566-570. PubMed ID: 29742190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.